Malaria – breakthrough in understanding the side effects of mefloquine

Two British scientists, Dr Ashley Croft and Dr Andrew Herxheimer, have published a paper which for the first time tries to explain the adverse effects of the controversial antimalaria drug, mefloquine (Lariam®).

Mefloquine, made by the Swiss drug company Hoffmann-La Roche, is used both to treat and prevent malaria. Since the 1980s doctors have used it to treat around 2 million people with malaria, and about 15 million travellers have used mefloquine as malaria prophylaxis.

Although many mefloquine users tolerate the drug well, in others it can cause a wide range of neuropsychiatric and other disturbing side effects, including hallucinations, nightmares, anxiety, tremor and psychosis. The first randomised controlled trial of mefloquine use in general travellers was published late last year in Clinical Infectious Diseases. One-third of the travellers using mefloquine reported neuropsychiatric adverse effects, and 6% of all mefloquine users reported at least one adverse event serious enough to require medical advice.

Media Contact

Andrew Herxheimer alphagalileo

All latest news from the category: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Back to home

Comments (0)

Write a comment

Newest articles

Microscopic basis of a new form of quantum magnetism

Not all magnets are the same. When we think of magnetism, we often think of magnets that stick to a refrigerator’s door. For these types of magnets, the electronic interactions…

An epigenome editing toolkit to dissect the mechanisms of gene regulation

A study from the Hackett group at EMBL Rome led to the development of a powerful epigenetic editing technology, which unlocks the ability to precisely program chromatin modifications. Understanding how…

NASA selects UF mission to better track the Earth’s water and ice

NASA has selected a team of University of Florida aerospace engineers to pursue a groundbreaking $12 million mission aimed at improving the way we track changes in Earth’s structures, such…

Partners & Sponsors